Exendin-9,39

N/A

Report date: 2025/05/15 20:00:08

Base Information

Drug NameExendin-9,39
Drug Alias NameN/A
ClassificationBiologics
Mechanisms of ActionGlucagon-like peptide 1 receptor antagonists
TargetsGlucagon-like peptide 1 receptor
Therapy Area/IndicationsGenetic Predisposition to DiseaseObesityPrediabetic State +[5] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesMayo Clinic
China Registration ClassN/A

Develop Information

Active CompaniesMayo Clinic
Inactive CompaniesN/A
Active IndicationsGenetic Predisposition to DiseasePrediabetic StateDiabetes Mellitus, Type 2
Inactive IndicationsObesityDiabetes Mellitus

Other Information

ATC CodeN/A
Related LinksN/A